BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wikman H, Kettunen E, Seppänen JK, Karjalainen A, Hollmén J, Anttila S, Knuutila S. Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array. Oncogene. 2002;21:5804-5813. [PMID: 12173052 DOI: 10.1038/sj.onc.1205726] [Cited by in Crossref: 123] [Cited by in F6Publishing: 112] [Article Influence: 6.2] [Reference Citation Analysis]
Number Citing Articles
1 Tamaskar I, Zhou M. Clinical implications of caveolins in malignancy and their potential as therapeutic targets. Curr Oncol Rep 2008;10:101-6. [DOI: 10.1007/s11912-008-0017-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
2 Letellier E, Schmitz M, Baig K, Beaume N, Schwartz C, Frasquilho S, Antunes L, Marcon N, Nazarov PV, Vallar L, Even J, Haan S. Identification of SOCS2 and SOCS6 as biomarkers in human colorectal cancer. Br J Cancer 2014;111:726-35. [PMID: 25025962 DOI: 10.1038/bjc.2014.377] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
3 Järvinen TA, Liu ET. HER-2/neu and topoisomerase IIalpha in breast cancer. Breast Cancer Res Treat 2003;78:299-311. [PMID: 12755489 DOI: 10.1023/a:1023077507295] [Cited by in Crossref: 62] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
4 Hartel M, Narla G, Wente MN, Giese NA, Martignoni ME, Martignetti JA, Friess H, Friedman SL. Increased alternative splicing of the KLF6 tumour suppressor gene correlates with prognosis and tumour grade in patients with pancreatic cancer. Eur J Cancer 2008;44:1895-903. [PMID: 18691883 DOI: 10.1016/j.ejca.2008.06.030] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
5 Chen K, Chen Y, Zhu XD, Bai YS, Wei XZ, Wang CF, Chen ZQ, Li M. Expression and significance of Kruppel-like factor 6 gene in osteosarcoma. Int Orthop 2012;36:2107-11. [PMID: 22855058 DOI: 10.1007/s00264-012-1626-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
6 Chhabra Y, Wong HY, Nikolajsen LF, Steinocher H, Papadopulos A, Tunny KA, Meunier FA, Smith AG, Kragelund BB, Brooks AJ, Waters MJ. A growth hormone receptor SNP promotes lung cancer by impairment of SOCS2-mediated degradation. Oncogene 2018;37:489-501. [PMID: 28967904 DOI: 10.1038/onc.2017.352] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
7 Daigeler A, Chromik AM, Haendschke K, Emmelmann S, Siepmann M, Hensel K, Schmitz G, Klein-Hitpass L, Steinau HU, Lehnhardt M, Hauser J. Synergistic effects of sonoporation and taurolidin/TRAIL on apoptosis in human fibrosarcoma. Ultrasound Med Biol 2010;36:1893-906. [PMID: 20870344 DOI: 10.1016/j.ultrasmedbio.2010.08.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
8 Sun Z, Yang P, Aubry MC, Kosari F, Endo C, Molina J, Vasmatzis G. Can gene expression profiling predict survival for patients with squamous cell carcinoma of the lung? Mol Cancer 2004;3:35. [PMID: 15579197 DOI: 10.1186/1476-4598-3-35] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
9 Jiang F, Yin Z, Caraway NP, Li R, Katz RL. Genomic profiles in stage I primary non small cell lung cancer using comparative genomic hybridization analysis of cDNA microarrays. Neoplasia 2004;6:623-35. [PMID: 15548372 DOI: 10.1593/neo.04142] [Cited by in Crossref: 68] [Cited by in F6Publishing: 50] [Article Influence: 4.0] [Reference Citation Analysis]
10 Quest AF, Gutierrez-Pajares JL, Torres VA. Caveolin-1: an ambiguous partner in cell signalling and cancer. J Cell Mol Med. 2008;12:1130-1150. [PMID: 18400052 DOI: 10.1111/j.1582-4934.2008.00331.x] [Cited by in Crossref: 111] [Cited by in F6Publishing: 116] [Article Influence: 7.9] [Reference Citation Analysis]
11 Lee C, Fotovati A, Triscott J, Chen J, Venugopal C, Singhal A, Dunham C, Kerr JM, Verreault M, Yip S, Wakimoto H, Jones C, Jayanthan A, Narendran A, Singh SK, Dunn SE. Polo-like kinase 1 inhibition kills glioblastoma multiforme brain tumor cells in part through loss of SOX2 and delays tumor progression in mice. Stem Cells 2012;30:1064-75. [PMID: 22415968 DOI: 10.1002/stem.1081] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 4.9] [Reference Citation Analysis]
12 Poppinga WJ, Muñoz-Llancao P, González-Billault C, Schmidt M. A-kinase anchoring proteins: cAMP compartmentalization in neurodegenerative and obstructive pulmonary diseases. Br J Pharmacol 2014;171:5603-23. [PMID: 25132049 DOI: 10.1111/bph.12882] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
13 Yerian LM, Anders RA, Tretiakova M, Hart J. Caveolin and Thrombospondin Expression During Hepatocellular Carcinogenesis: . The American Journal of Surgical Pathology 2004;28:357-64. [DOI: 10.1097/00000478-200403000-00008] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
14 Ouellet V, Ling TH, Normandin K, Madore J, Lussier C, Barrès V, Bachvarov D, Rancourt C, Tonin PN, Provencher DM, Mes-Masson AM. Immunohistochemical profiling of benign, low malignant potential and low grade serous epithelial ovarian tumors. BMC Cancer 2008;8:346. [PMID: 19032793 DOI: 10.1186/1471-2407-8-346] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
15 Linkov F, Yurkovetsky Z, Lokshin A. Biomarker approaches to the development of cancer screening tests: can cancer blood tests become a routine health check-up? Future Oncology 2007;3:295-8. [DOI: 10.2217/14796694.3.3.295] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
16 Yildirim M, Paydas S, Tanriverdi K, Seydaoglu G, Disel U, Yavuz S. Gravin gene expression in acute leukaemias: clinical importance and review of the literature. Leuk Lymphoma 2007;48:1167-72. [PMID: 17577780 DOI: 10.1080/10428190701377055] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
17 Jasmin JF, Mercier I, Sotgia F, Lisanti MP. SOCS proteins and caveolin-1 as negative regulators of endocrine signaling. Trends Endocrinol Metab. 2006;17:150-158. [PMID: 16616514 DOI: 10.1016/j.tem.2006.03.007] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 1.9] [Reference Citation Analysis]
18 Granville CA, Dennis PA. An Overview of Lung Cancer Genomics and Proteomics. Am J Respir Cell Mol Biol 2005;32:169-76. [DOI: 10.1165/rcmb.f290] [Cited by in Crossref: 116] [Cited by in F6Publishing: 39] [Article Influence: 6.8] [Reference Citation Analysis]
19 Miller ME, Michaylira CZ, Simmons JG, Ney DM, Dahly EM, Heath JK, Lund PK. Suppressor of cytokine signaling-2: a growth hormone-inducible inhibitor of intestinal epithelial cell proliferation. Gastroenterology 2004;127:570-81. [PMID: 15300589 DOI: 10.1053/j.gastro.2004.05.016] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 2.1] [Reference Citation Analysis]
20 Tanaka F, Sonoda H, Okamoto M, Mimori K, Utsunomiya T, Inoue H, Hanai T, Mori M. TIMP-3 and Phosphatidylinositol 3-kinase Genes Were Found to Be Related to the Progression of Colon Cancer in a Comparison of Pneumoperitoneum and Laparotomy in a Murine Model. Surg Today 2007;37:220-5. [DOI: 10.1007/s00595-006-3370-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
21 Chiquet-ehrismann R, Chiquet M. Tenascins: regulation and putative functions during pathological stress: Tenascins in pathological stress. J Pathol 2003;200:488-99. [DOI: 10.1002/path.1415] [Cited by in Crossref: 361] [Cited by in F6Publishing: 342] [Article Influence: 19.0] [Reference Citation Analysis]
22 Kurokawa Y, Matoba R, Takemasa I, Nagano H, Dono K, Nakamori S, Umeshita K, Sakon M, Ueno N, Oba S. Molecular-based prediction of early recurrence in hepatocellular carcinoma. J Hepatol. 2004;41:284-291. [PMID: 15288478 DOI: 10.1016/j.jhep.2004.04.031] [Cited by in Crossref: 83] [Cited by in F6Publishing: 73] [Article Influence: 4.9] [Reference Citation Analysis]
23 Tang Y, Zeng X, He F, Liao Y, Qian N, Toi M. Caveolin-1 is related to invasion, survival, and poor prognosis in hepatocellular cancer. Med Oncol 2012;29:977-84. [PMID: 21416157 DOI: 10.1007/s12032-011-9900-5] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
24 Ciribilli Y, Borlak J. Oncogenomics of c-Myc transgenic mice reveal novel regulators of extracellular signaling, angiogenesis and invasion with clinical significance for human lung adenocarcinoma. Oncotarget 2017;8:101808-31. [PMID: 29254206 DOI: 10.18632/oncotarget.21981] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
25 Ciribilli Y, Singh P, Inga A, Borlak J. c-Myc targeted regulators of cell metabolism in a transgenic mouse model of papillary lung adenocarcinoma. Oncotarget 2016;7:65514-39. [PMID: 27602772 DOI: 10.18632/oncotarget.11804] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
26 He Y, Zhou Z, Hofstetter WL, Zhou Y, Hu W, Guo C, Wang L, Guo W, Pataer A, Correa AM, Lu Y, Wang J, Diao L, Byers LA, Wistuba II, Roth JA, Swisher SG, Heymach JV, Fang B. Aberrant expression of proteins involved in signal transduction and DNA repair pathways in lung cancer and their association with clinical parameters. PLoS One 2012;7:e31087. [PMID: 22348039 DOI: 10.1371/journal.pone.0031087] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
27 Salem AF, Bonuccelli G, Bevilacqua G, Arafat H, Pestell RG, Sotgia F, Lisanti MP. Caveolin-1 promotes pancreatic cancer cell differentiation and restores membranous E-cadherin via suppression of the epithelial-mesenchymal transition. Cell Cycle 2011;10:3692-700. [PMID: 22041584 DOI: 10.4161/cc.10.21.17895] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 3.1] [Reference Citation Analysis]
28 Wang W, He J, Lu H, Kong Q, Lin S. KRT8 and KRT19, associated with EMT, are hypomethylated and overexpressed in lung adenocarcinoma and link to unfavorable prognosis. Biosci Rep 2020;40:BSR20193468. [PMID: 32519739 DOI: 10.1042/BSR20193468] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
29 Ren M, Liu F, Zhu Y, Li Y, Lang R, Fan Y, Gu F, Zhang X, Fu L. Absence of caveolin-1 expression in carcinoma-associated fibroblasts of invasive micropapillary carcinoma of the breast predicts poor patient outcome. Virchows Arch 2014;465:291-8. [DOI: 10.1007/s00428-014-1614-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
30 Duzcan F, Duzcan SE, Sen S, Yorukoglu K, Caner V, Sen Turk N, Cetin GO, Kelten C, Tuna B, Sarsik B, Tepeli E. Expression and Amplification of Topoisomerase-2α in Type 1 and Type 2 Papillary Renal Cell Carcinomas and Its Correlation with HER2/neu Amplification. Pathol Oncol Res 2011;17:697-703. [DOI: 10.1007/s12253-011-9372-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
31 Sloan KA, Marquez HA, Li J, Cao Y, Hinds A, O’Hara CJ, Kathuria S, Ramirez MI, Williams MC, Kathuria H. Increased PEA3/E1AF and decreased Net/Elk-3, both ETS proteins, characterize human NSCLC progression and regulate caveolin-1 transcription in Calu-1 and NCI-H23 NSCLC cell lines. Carcinogenesis. 2009;30:1433-1442. [PMID: 19483189 DOI: 10.1093/carcin/bgp129] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
32 Maniatis NA, Chernaya O, Shinin V, Minshall RD. Caveolins and lung function. Adv Exp Med Biol. 2012;729:157-179. [PMID: 22411320 DOI: 10.1007/978-1-4614-1222-911] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Hoefer J, Kern J, Ofer P, Eder IE, Schäfer G, Dietrich D, Kristiansen G, Geley S, Rainer J, Gunsilius E, Klocker H, Culig Z, Puhr M. SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer. Endocr Relat Cancer 2014;21:175-87. [PMID: 24280133 DOI: 10.1530/ERC-13-0446] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
34 Qian N, Ueno T, Kawaguchi-Sakita N, Kawashima M, Yoshida N, Mikami Y, Wakasa T, Shintaku M, Tsuyuki S, Inamoto T, Toi M. Prognostic significance of tumor/stromal caveolin-1 expression in breast cancer patients. Cancer Sci 2011;102:1590-6. [PMID: 21585620 DOI: 10.1111/j.1349-7006.2011.01985.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 48] [Article Influence: 4.0] [Reference Citation Analysis]
35 Duregon E, Senetta R, Pittaro A, Verdun di Cantogno L, Stella G, De Blasi P, Zorzetto M, Mantovani C, Papotti M, Cassoni P. CAVEOLIN-1 expression in brain metastasis from lung cancer predicts worse outcome and radioresistance, irrespective of tumor histotype. Oncotarget 2015;6:29626-36. [PMID: 26315660 DOI: 10.18632/oncotarget.4988] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
36 Singh V, Lamaze C. Membrane tension buffering by caveolae: a role in cancer? Cancer Metastasis Rev 2020;39:505-17. [PMID: 32474691 DOI: 10.1007/s10555-020-09899-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
37 Mostafa MR, Yahia RS, Abd El Messih HM, El-Sisy E, El Ghannam DM. Gravin gene expression in acute myeloid leukemia. Med Oncol 2013;30:548. [PMID: 23543478 DOI: 10.1007/s12032-013-0548-1] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
38 Miller MS, Miller LD. RAS mutations and oncogenesis: Not all RAS mutations are created equally. Front Genet. 2011;2:100. [PMID: 22303394 DOI: 10.3389/fgene.2011.00100] [Cited by in Crossref: 17] [Cited by in F6Publishing: 28] [Article Influence: 1.7] [Reference Citation Analysis]
39 Hebert C, Norris K, Scheper MA, Nikitakis N, Sauk JJ. High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma. Mol Cancer. 2007;6:5. [PMID: 17222355 DOI: 10.1186/1476-4598-6-5] [Cited by in Crossref: 205] [Cited by in F6Publishing: 212] [Article Influence: 13.7] [Reference Citation Analysis]
40 Kung WW, Ramachandran S, Makukhin N, Bruno E, Ciulli A. Structural insights into substrate recognition by the SOCS2 E3 ubiquitin ligase. Nat Commun 2019;10:2534. [PMID: 31182716 DOI: 10.1038/s41467-019-10190-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
41 Mi L, Zhu F, Yang X, Lu J, Zheng Y, Zhao Q, Wen X, Lu A, Wang M, Zheng M, Ji J, Sun J. The metastatic suppressor NDRG1 inhibits EMT, migration and invasion through interaction and promotion of caveolin-1 ubiquitylation in human colorectal cancer cells. Oncogene 2017;36:4323-35. [PMID: 28346422 DOI: 10.1038/onc.2017.74] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 9.0] [Reference Citation Analysis]
42 Maniatis NA, Chernaya O, Shinin V, Minshall RD. Caveolins and lung function. Adv Exp Med Biol 2012;729:157-79. [PMID: 22411320 DOI: 10.1007/978-1-4614-1222-9_11] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
43 Haffner MC, Petridou B, Peyrat JP, Révillion F, Müller-Holzner E, Daxenbichler G, Marth C, Doppler W. Favorable prognostic value of SOCS2 and IGF-I in breast cancer. BMC Cancer. 2007;7:136. [PMID: 17651480 DOI: 10.1186/1471-2407-7-136] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 2.7] [Reference Citation Analysis]
44 Jo U, Whang YM, Kim HK, Kim YH. AKAP12alpha is associated with promoter methylation in lung cancer. Cancer Res Treat 2006;38:144-51. [PMID: 19771275 DOI: 10.4143/crt.2006.38.3.144] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
45 Lai E, Tai Y, Jiang J, Zhao C, Xiao Y, Quan X, Wu H, Gao J. Prognostic evaluation and immune infiltration analysis of five bioinformatic selected genes in hepatocellular carcinoma. J Cell Mol Med 2021;25:11128-41. [PMID: 34726341 DOI: 10.1111/jcmm.17035] [Reference Citation Analysis]
46 Meyerson M, Carbone D. Genomic and Proteomic Profiling of Lung Cancers: Lung Cancer Classification in the Age of Targeted Therapy. JCO 2005;23:3219-26. [DOI: 10.1200/jco.2005.15.511] [Cited by in Crossref: 71] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
47 Körner A, Mudduluru G, Manegold C, Allgayer H. Enzastaurin inhibits invasion and metastasis in lung cancer by diverse molecules. Br J Cancer 2010;103:802-11. [PMID: 20736951 DOI: 10.1038/sj.bjc.6605818] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
48 Ferraro B, Bepler G, Sharma S, Cantor A, Haura EB. EGR1 Predicts PTEN and Survival in Patients With Non–Small-Cell Lung Cancer. JCO 2005;23:1921-6. [DOI: 10.1200/jco.2005.08.127] [Cited by in Crossref: 48] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
49 Sun M, Guan Z, Liu S, Zhou X, Wang N, Shao S, Lin D. Caveolin-1 interferes cell growth of lung cancer NCI-H446 cell through the interactions with phospho-ERK1/2, estrogen receptor and progestin receptor. Biomedicine & Pharmacotherapy 2012;66:242-8. [DOI: 10.1016/j.biopha.2011.11.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
50 Uen Y, Fang C, Lin C, Hseu Y, Hung S, Sun D, Lin K. Ceramide synthase 6 predicts the prognosis of human gastric cancer: It functions as an oncoprotein by dysregulating the SOCS2/JAK2/STAT3 pathway. Molecular Carcinogenesis 2018;57:1675-89. [DOI: 10.1002/mc.22888] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
51 Qiu X, Zheng J, Guo X, Gao X, Liu H, Tu Y, Zhang Y. Reduced expression of SOCS2 and SOCS6 in hepatocellular carcinoma correlates with aggressive tumor progression and poor prognosis. Mol Cell Biochem 2013;378:99-106. [PMID: 23475171 DOI: 10.1007/s11010-013-1599-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
52 Mano MS, Rosa DD, De Azambuja E, Ismael GF, Durbecq V. The 17q12-q21 amplicon: Her2 and topoisomerase-IIalpha and their importance to the biology of solid tumours. Cancer Treat Rev 2007;33:64-77. [PMID: 17113234 DOI: 10.1016/j.ctrv.2006.10.001] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 3.3] [Reference Citation Analysis]
53 Venkatesan N, Kandalam M, Pasricha G, Sumantran V, Manfioletti G, Ono SJ, Reddy MA, Krishnakumar S. Expression of high mobility group A2 protein in retinoblastoma and its association with clinicopathologic features. J Pediatr Hematol Oncol. 2009;31:209-214. [PMID: 19262251 DOI: 10.1097/mph.0b013e318197978d] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
54 Tenzer S, Leidinger P, Backes C, Huwer H, Hildebrandt A, Lenhof HP, Wesse T, Franke A, Meese E, Keller A. Integrated quantitative proteomic and transcriptomic analysis of lung tumor and control tissue: a lung cancer showcase. Oncotarget 2016;7:14857-70. [PMID: 26930711 DOI: 10.18632/oncotarget.7562] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
55 Zhang ZB, Cai L, Zheng SG, Xiong Y, Dong JH. Overexpression of caveolin-1 in hepatocellular carcinoma with metastasis and worse prognosis: correlation with vascular endothelial growth factor, microvessel density and unpaired artery. Pathol Oncol Res 2009;15:495-502. [PMID: 19434519 DOI: 10.1007/s12253-008-9144-7] [Cited by in Crossref: 35] [Cited by in F6Publishing: 40] [Article Influence: 2.9] [Reference Citation Analysis]
56 Wood SL, Pernemalm M, Crosbie PA, Whetton AD. Molecular histology of lung cancer: from targets to treatments. Cancer Treat Rev 2015;41:361-75. [PMID: 25825324 DOI: 10.1016/j.ctrv.2015.02.008] [Cited by in Crossref: 93] [Cited by in F6Publishing: 104] [Article Influence: 13.3] [Reference Citation Analysis]
57 Liu P, Tsai J, Chiu C, Hwang J, Chou S, Wang C, Wu S, Chen Y, Chen W, Chen Y, Chong I. Decreased expression of thrombomodulin is correlated with tumor cell invasiveness and poor prognosis in nonsmall cell lung cancer: TM EXPRESSION IN NSCLC. Mol Carcinog 2010;49:874-81. [DOI: 10.1002/mc.20663] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
58 Wong GS, Rustgi AK. Matricellular proteins: priming the tumour microenvironment for cancer development and metastasis. Br J Cancer 2013;108:755-61. [PMID: 23322204 DOI: 10.1038/bjc.2012.592] [Cited by in Crossref: 102] [Cited by in F6Publishing: 89] [Article Influence: 11.3] [Reference Citation Analysis]
59 Best CJM, Leiva IM, Chuaqui RF, Gillespie JW, Duray PH, Murgai M, Zhao Y, Simon R, Kang JJ, Green JE, Bostwick DG, Linehan WM, Emmert-buck MR. Molecular Differentiation of High- and Moderate-Grade Human Prostate Cancer by cDNA Microarray Analysis: . Diagnostic Molecular Pathology 2003;12:63-70. [DOI: 10.1097/00019606-200306000-00001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
60 Schvartzman JM, Sotillo R, Benezra R. Mitotic chromosomal instability and cancer: mouse modelling of the human disease. Nat Rev Cancer. 2010;10:102-115. [PMID: 20094045 DOI: 10.1038/nrc2781] [Cited by in Crossref: 289] [Cited by in F6Publishing: 277] [Article Influence: 24.1] [Reference Citation Analysis]
61 Liu YB, Wei ZX, Li L, Li HS, Chen H, Li XW. Construction and analysis of SSH cDNA library of human vascular endothelial cells related to gastrocarcinoma. World J Gastroenterol 2003; 9(11): 2419-2423 [PMID: 14606068 DOI: 10.3748/wjg.v9.i11.2419] [Cited by in CrossRef: 1] [Article Influence: 0.1] [Reference Citation Analysis]
62 Zhou Y, Zhang Z, Wang N, Chen J, Zhang X, Guo M, John Zhong L, Wang Q. Suppressor of cytokine signalling-2 limits IGF1R-mediated regulation of epithelial-mesenchymal transition in lung adenocarcinoma. Cell Death Dis 2018;9:429. [PMID: 29559623 DOI: 10.1038/s41419-018-0457-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
63 Travis WD. E12-01: NCI Director's challenge gene profiling of lung adenocarcinomas: impact on histologic classification. Journal of Thoracic Oncology 2007;2:S254-6. [DOI: 10.1097/01.jto.0000283030.74046.34] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
64 Bai Q, Liu H, Guo H, Lin H, Song X, Jin Y, Liu Y, Guo H, Liang S, Song R, Wang J, Qu Z, Guo H, Jiang H, Liu L, Yang H. Identification of Hub Genes Associated With Development and Microenvironment of Hepatocellular Carcinoma by Weighted Gene Co-expression Network Analysis and Differential Gene Expression Analysis. Front Genet 2020;11:615308. [PMID: 33414813 DOI: 10.3389/fgene.2020.615308] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
65 Du L, Zhao Z, Ma X, Hsiao TH, Chen Y, Young E, Suraokar M, Wistuba I, Minna JD, Pertsemlidis A. miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer. Oncogene. 2014;33:4307-4315. [PMID: 24037530 DOI: 10.1038/onc.2013.381] [Cited by in Crossref: 49] [Cited by in F6Publishing: 56] [Article Influence: 5.4] [Reference Citation Analysis]
66 Bastide K, Ugolin N, Levalois C, Bernaudin JF, Chevillard S. Are adenosquamous lung carcinomas a simple mix of adenocarcinomas and squamous cell carcinomas, or more complex at the molecular level? Lung Cancer 2010;68:1-9. [PMID: 20004040 DOI: 10.1016/j.lungcan.2009.11.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
67 Kho PS, Wang Z, Zhuang L, Li Y, Chew JL, Ng HH, Liu ET, Yu Q. p53-regulated transcriptional program associated with genotoxic stress-induced apoptosis. J Biol Chem 2004;279:21183-92. [PMID: 15016801 DOI: 10.1074/jbc.M311912200] [Cited by in Crossref: 110] [Cited by in F6Publishing: 55] [Article Influence: 6.1] [Reference Citation Analysis]
68 Gai X, Lu Z, Tu K, Liang Z, Zheng X. Caveolin-1 is up-regulated by GLI1 and contributes to GLI1-driven EMT in hepatocellular carcinoma. PLoS One 2014;9:e84551. [PMID: 24454730 DOI: 10.1371/journal.pone.0084551] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
69 Horlings H, Demant P. Lung tumor location and lymphocyte infiltration in mice are genetically determined. Exp Lung Res 2005;31:513-25. [PMID: 16019985 DOI: 10.1080/01902140590918740] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
70 Chappell NP, Teng PN, Hood BL, Wang G, Darcy KM, Hamilton CA, Maxwell GL, Conrads TP. Mitochondrial proteomic analysis of cisplatin resistance in ovarian cancer. J Proteome Res 2012;11:4605-14. [PMID: 22900918 DOI: 10.1021/pr300403d] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]
71 Rödel F, Capalbo G, Rödel C, Weiss C. Caveolin-1 as a prognostic marker for local control after preoperative chemoradiation therapy in rectal cancer. Int J Radiat Oncol Biol Phys 2009;73:846-52. [PMID: 19131184 DOI: 10.1016/j.ijrobp.2008.10.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
72 Bogazzi F, Ultimieri F, Raggi F, Russo D, Costa A, Marciano E, Bartalena L, Martino E. Changes in the expression of suppressor of cytokine signalling (SOCS) 2 in the colonic mucosa of acromegalic patients are associated with hyperplastic polyps. Clin Endocrinol (Oxf) 2009;70:898-906. [PMID: 18844680 DOI: 10.1111/j.1365-2265.2008.03431.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
73 Michaylira CZ, Ramocki NM, Simmons JG, Tanner CK, McNaughton KK, Woosley JT, Greenhalgh CJ, Lund PK. Haplotype insufficiency for suppressor of cytokine signaling-2 enhances intestinal growth and promotes polyp formation in growth hormone-transgenic mice. Endocrinology 2006;147:1632-41. [PMID: 16410303 DOI: 10.1210/en.2005-1241] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
74 Wikman H, Ruosaari S, Nymark P, Sarhadi VK, Saharinen J, Vanhala E, Karjalainen A, Hollmén J, Knuutila S, Anttila S. Gene expression and copy number profiling suggests the importance of allelic imbalance in 19p in asbestos-associated lung cancer. Oncogene 2007;26:4730-7. [DOI: 10.1038/sj.onc.1210270] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
75 Järvinen TA, Liu ET. Topoisomerase IIalpha gene (TOP2A) amplification and deletion in cancer--more common than anticipated. Cytopathology 2003;14:309-13. [PMID: 14632727 DOI: 10.1046/j.0956-5507.2003.00105.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 1.7] [Reference Citation Analysis]
76 Cui M, Sun J, Hou J, Fang T, Wang X, Ge C, Zhao F, Chen T, Xie H, Cui Y, Yao M, Li J, Li H. The suppressor of cytokine signaling 2 (SOCS2) inhibits tumor metastasis in hepatocellular carcinoma. Tumour Biol 2016;37:13521-31. [PMID: 27465557 DOI: 10.1007/s13277-016-5215-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
77 Cho DS, Yim H, Cho KS, Hong SJ, Cho NH, Kim SI, Ahn HS, Kim SJ. Impact of caveolin-1 expression on the prognosis of transitional cell carcinoma of the upper urinary tract. J Korean Med Sci 2008;23:296-301. [PMID: 18437015 DOI: 10.3346/jkms.2008.23.2.296] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
78 Kobayashi K, Nishioka M, Kohno T, Nakamoto M, Maeshima A, Aoyagi K, Sasaki H, Takenoshita S, Sugimura H, Yokota J. Identification of genes whose expression is upregulated in lung adenocarcinoma cells in comparison with type II alveolar cells and bronchiolar epithelial cells in vivo. Oncogene 2004;23:3089-96. [PMID: 14755238 DOI: 10.1038/sj.onc.1207433] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.4] [Reference Citation Analysis]
79 Han B, Poppinga WJ, Schmidt M. Scaffolding during the cell cycle by A-kinase anchoring proteins. Pflugers Arch 2015;467:2401-11. [PMID: 26202611 DOI: 10.1007/s00424-015-1718-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
80 Jasmin J, Frank PG, Lisanti MP. Chapter 11 Caveolin Proteins in Cardiopulmonary Disease and Lung Cancers. Caveolae and Lipid Rafts: Roles in Signal Transduction and the Pathogenesis of Human Disease. Elsevier; 2005. pp. 211-33. [DOI: 10.1016/s1569-2558(05)36011-5] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
81 Zhang C, Li C, Xu Y, Feng L, Shang D, Yang X, Han J, Sun Z, Li Y, Li X. Integrative analysis of lung development-cancer expression associations reveals the roles of signatures with inverse expression patterns. Mol Biosyst. 2015;11:1271-1284. [PMID: 25720795 DOI: 10.1039/c5mb00061k] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
82 Wikman H, Nymark P, Väyrynen A, Jarmalaite S, Kallioniemi A, Salmenkivi K, Vainio-siukola K, Husgafvel-pursiainen K, Knuutila S, Wolf M, Anttila S. CDK4 is a probable target gene in a novel amplicon at 12q13.3-q14.1 in lung cancer: CDK4 a Probable Target in Lung Cancer. Genes Chromosom Cancer 2005;42:193-9. [DOI: 10.1002/gcc.20122] [Cited by in Crossref: 68] [Cited by in F6Publishing: 59] [Article Influence: 3.8] [Reference Citation Analysis]
83 Tsai JR, Wang HM, Liu PL, Chen YH, Yang MC, Chou SH, Cheng YJ, Yin WH, Hwang JJ, Chong IW. High expression of heme oxygenase-1 is associated with tumor invasiveness and poor clinical outcome in non-small cell lung cancer patients. Cell Oncol (Dordr) 2012;35:461-71. [PMID: 23055342 DOI: 10.1007/s13402-012-0105-5] [Cited by in Crossref: 61] [Cited by in F6Publishing: 59] [Article Influence: 6.1] [Reference Citation Analysis]
84 Tsai JR, Liu PL, Chen YH, Chou SH, Yang MC, Cheng YJ, Hwang JJ, Yin WH, Chong IW. Ginkgo biloba extract decreases non-small cell lung cancer cell migration by downregulating metastasis-associated factor heat-shock protein 27. PLoS One 2014;9:e91331. [PMID: 24618684 DOI: 10.1371/journal.pone.0091331] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
85 Sasi W, Sharma AK, Mokbel K. The role of suppressors of cytokine signalling in human neoplasms. Mol Biol Int 2014;2014:630797. [PMID: 24757565 DOI: 10.1155/2014/630797] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
86 Tsai JR, Liu PL, Chen YH, Chou SH, Cheng YJ, Hwang JJ, Chong IW. Curcumin Inhibits Non-Small Cell Lung Cancer Cells Metastasis through the Adiponectin/NF-κb/MMPs Signaling Pathway. PLoS One 2015;10:e0144462. [PMID: 26656720 DOI: 10.1371/journal.pone.0144462] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 6.1] [Reference Citation Analysis]
87 Sarhadi VK, Wikman H, Salmenkivi K, Kuosma E, Sioris T, Salo J, Karjalainen A, Knuutila S, Anttila S. Increased expression of high mobility group A proteins in lung cancer. J Pathol. 2006;209:206-212. [PMID: 16521118 DOI: 10.1002/path.1960] [Cited by in Crossref: 125] [Cited by in F6Publishing: 128] [Article Influence: 7.8] [Reference Citation Analysis]
88 Piessevaux J, Lavens D, Peelman F, Tavernier J. The many faces of the SOCS box. Cytokine Growth Factor Rev. 2008;19:371-381. [PMID: 18948053 DOI: 10.1016/j.cytogfr.2008.08.006] [Cited by in Crossref: 120] [Cited by in F6Publishing: 125] [Article Influence: 8.6] [Reference Citation Analysis]
89 Hebert C, Norris K, Scheper MA, Nikitakis N, Sauk JJ. High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma. Mol Cancer 2007;6:5. [PMID: 17222355 DOI: 10.1186/1476-4598-6-5] [Cited by in Crossref: 209] [Cited by in F6Publishing: 1] [Article Influence: 13.9] [Reference Citation Analysis]
90 Sun L, Li M, Jiang L, Tan L. Comparative analysis of the gene co-regulatory network of normal and cancerous lung. Physica A: Statistical Mechanics and its Applications 2007;384:739-46. [DOI: 10.1016/j.physa.2007.05.067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
91 Turpaev KT. [Role of transcription factor AP-1 in integration of cellular signalling systems]. Mol Biol (Mosk) 2006;40:945-61. [PMID: 17209422 DOI: 10.1134/s0026893306060148] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
92 Gelman IH. Emerging Roles for SSeCKS/Gravin/AKAP12 in the Control of Cell Proliferation, Cancer Malignancy, and Barriergenesis. Genes Cancer 2010;1:1147-56. [PMID: 21779438 DOI: 10.1177/1947601910392984] [Cited by in Crossref: 69] [Cited by in F6Publishing: 65] [Article Influence: 6.3] [Reference Citation Analysis]
93 Schlott T, Eiffert H, Bohne W, Landgrebe J, Brunner E, Spielbauer B, Knight B. Chlamydia trachomatis modulates expression of tumor suppressor gene caveolin-1 and oncogene C-myc in the transformation zone of non-neoplastic cervical tissue. Gynecol Oncol 2005;98:409-19. [PMID: 16005053 DOI: 10.1016/j.ygyno.2005.04.034] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
94 Williams TM, Lisanti MP. Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol Cell Physiol. 2005;288:C494-C506. [PMID: 15692148 DOI: 10.1152/ajpcell.00458.2004] [Cited by in Crossref: 373] [Cited by in F6Publishing: 360] [Article Influence: 21.9] [Reference Citation Analysis]
95 Liu P, Tsai J, Hwang J, Chou S, Cheng Y, Lin F, Chen Y, Hung C, Chen W, Chen Y, Chong I. High-Mobility Group Box 1–Mediated Matrix Metalloproteinase-9 Expression in Non–Small Cell Lung Cancer Contributes to Tumor Cell Invasiveness. Am J Respir Cell Mol Biol 2010;43:530-8. [DOI: 10.1165/rcmb.2009-0269oc] [Cited by in Crossref: 58] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
96 Gupta R, Toufaily C, Annabi B. Caveolin and cavin family members: dual roles in cancer. Biochimie. 2014;107 Pt B:188-202. [PMID: 25241255 DOI: 10.1016/j.biochi.2014.09.010] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 6.1] [Reference Citation Analysis]
97 Li B, Feng W, Luo O, Xu T, Cao Y, Wu H, Yu D, Ding Y. Development and Validation of a Three-gene Prognostic Signature for Patients with Hepatocellular Carcinoma. Sci Rep 2017;7:5517. [PMID: 28717245 DOI: 10.1038/s41598-017-04811-5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 33] [Article Influence: 5.4] [Reference Citation Analysis]
98 Kremer-tal S, Reeves HL, Narla G, Thung SN, Schwartz M, Difeo A, Katz A, Bruix J, Bioulac-sage P, Martignetti JA, Friedman SL. Frequent inactivation of the tumor suppressor Kruppel-like factor 6 (KLF6) in hepatocellular carcinoma. Hepatology 2004;40:1047-52. [DOI: 10.1002/hep.20460] [Cited by in Crossref: 103] [Cited by in F6Publishing: 93] [Article Influence: 5.7] [Reference Citation Analysis]
99 O'Sullivan S, Medina C, Ledwidge M, Radomski MW, Gilmer JF. Nitric oxide-matrix metaloproteinase-9 interactions: biological and pharmacological significance--NO and MMP-9 interactions. Biochim Biophys Acta 2014;1843:603-17. [PMID: 24333402 DOI: 10.1016/j.bbamcr.2013.12.006] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 7.1] [Reference Citation Analysis]
100 de Andrés MC, Imagawa K, Hashimoto K, Gonzalez A, Goldring MB, Roach HI, Oreffo RO. Suppressors of cytokine signalling (SOCS) are reduced in osteoarthritis. Biochem Biophys Res Commun 2011;407:54-9. [PMID: 21352802 DOI: 10.1016/j.bbrc.2011.02.101] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 3.4] [Reference Citation Analysis]
101 Michaylira CZ, Simmons JG, Ramocki NM, Scull BP, McNaughton KK, Fuller CR, Lund PK. Suppressor of cytokine signaling-2 limits intestinal growth and enterotrophic actions of IGF-I in vivo. Am J Physiol Gastrointest Liver Physiol 2006;291:G472-81. [PMID: 16574995 DOI: 10.1152/ajpgi.00218.2005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
102 Zhang Q, Tan XP, Yuan YS, Hu CM, He CH, Wang WZ, Li JC, Zhao Q, Liu NZ. Decreased expression of KLF6 and its significance in gastric carcinoma. Med Oncol 2010;27:1295-302. [PMID: 19967571 DOI: 10.1007/s12032-009-9377-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
103 Zhang ZB, Shi Z, Yang LF, Gao HB. Caveolin-1 Knockdown Decreases SMMC7721 Human Hepatocellular Carcinoma Cell Invasiveness by Inhibiting Vascular Endothelial Growth Factor-Induced Angiogenesis. Can J Gastroenterol Hepatol 2020;2020:8880888. [PMID: 32676485 DOI: 10.1155/2020/8880888] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
104 Selamat SA, Chung BS, Girard L, Zhang W, Zhang Y, Campan M, Siegmund KD, Koss MN, Hagen JA, Lam WL, Lam S, Gazdar AF, Laird-Offringa IA. Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression. Genome Res 2012;22:1197-211. [PMID: 22613842 DOI: 10.1101/gr.132662.111] [Cited by in Crossref: 286] [Cited by in F6Publishing: 302] [Article Influence: 28.6] [Reference Citation Analysis]
105 Ceruti P, Principe M, Capello M, Cappello P, Novelli F. Three are better than one: plasminogen receptors as cancer theranostic targets. Exp Hematol Oncol 2013;2:12. [PMID: 23594883 DOI: 10.1186/2162-3619-2-12] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
106 Winkles JA, Alberts GF. Differential regulation of polo-like kinase 1, 2, 3, and 4 gene expression in mammalian cells and tissues. Oncogene 2005;24:260-6. [PMID: 15640841 DOI: 10.1038/sj.onc.1208219] [Cited by in Crossref: 105] [Cited by in F6Publishing: 97] [Article Influence: 6.2] [Reference Citation Analysis]
107 Hayes DN, Monti S, Parmigiani G, Gilks CB, Naoki K, Bhattacharjee A, Socinski MA, Perou C, Meyerson M. Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts. J Clin Oncol. 2006;24:5079-5090. [PMID: 17075127 DOI: 10.1200/jco.2005.05.1748] [Cited by in Crossref: 183] [Cited by in F6Publishing: 99] [Article Influence: 11.4] [Reference Citation Analysis]
108 Boultwood J, Pellagatti A, Watkins F, Campbell LJ, Esoof N, Cross NC, Eagleton H, Littlewood TJ, Fidler C, Wainscoat JS. Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia. Br J Haematol 2004;126:508-11. [PMID: 15287943 DOI: 10.1111/j.1365-2141.2004.05067.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
109 Narla G, Friedman SL, Martignetti JA. Krüppel cripples prostate cancer: KLF6 progress and prospects. Am J Pathol. 2003;162:1047-1052. [PMID: 12651597 DOI: 10.1016/s0002-9440(10)63901-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
110 Lebrun P, Cognard E, Gontard P, Bellon-Paul R, Filloux C, Berthault MF, Magnan C, Ruberte J, Luppo M, Pujol A, Pachera N, Herchuelz A, Bosch F, Van Obberghen E. The suppressor of cytokine signalling 2 (SOCS2) is a key repressor of insulin secretion. Diabetologia 2010;53:1935-46. [PMID: 20499047 DOI: 10.1007/s00125-010-1786-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
111 Kolokythas A, Miloro M, Zhou X. Review of MicroRNA Proposed Target Genes in Oral Cancer. Part II. J Oral Maxillofac Res 2011;2:e2. [PMID: 24421989 DOI: 10.5037/jomr.2011.2202] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
112 Fromigué O, Louis K, Dayem M, Milanini J, Pages G, Tartare-deckert S, Ponzio G, Hofman P, Barbry P, Auberger P, Mari B. Gene expression profiling of normal human pulmonary fibroblasts following coculture with non-small-cell lung cancer cells reveals alterations related to matrix degradation, angiogenesis, cell growth and survival. Oncogene 2003;22:8487-97. [DOI: 10.1038/sj.onc.1206918] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 1.7] [Reference Citation Analysis]
113 Quest AF, Leyton L, Párraga M. Caveolins, caveolae, and lipid rafts in cellular transport, signaling, and disease. Biochem Cell Biol 2004;82:129-44. [PMID: 15052333 DOI: 10.1139/o03-071] [Cited by in Crossref: 160] [Cited by in F6Publishing: 153] [Article Influence: 8.9] [Reference Citation Analysis]
114 Kettunen E, Anttila S, Seppänen JK, Karjalainen A, Edgren H, Lindström I, Salovaara R, Nissén AM, Salo J, Mattson K, Hollmén J, Knuutila S, Wikman H. Differentially expressed genes in nonsmall cell lung cancer: expression profiling of cancer-related genes in squamous cell lung cancer. Cancer Genet Cytogenet 2004;149:98-106. [PMID: 15036884 DOI: 10.1016/S0165-4608(03)00300-5] [Cited by in Crossref: 98] [Cited by in F6Publishing: 53] [Article Influence: 5.4] [Reference Citation Analysis]
115 Wu SG, Chang TH, Liu YN, Shih JY. MicroRNA in Lung Cancer Metastasis. Cancers (Basel) 2019;11:E265. [PMID: 30813457 DOI: 10.3390/cancers11020265] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 9.7] [Reference Citation Analysis]